These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12607724)

  • 1. Treatment of refractory Churg-Strauss-Syndrome (CSS) by TNF-alpha blockade.
    Arbach O; Gross WL; Gause A
    Immunobiology; 2002 Dec; 206(5):496-501. PubMed ID: 12607724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Symmetric polyarthritis in a patient with Churg-Strauss syndrome].
    Aries PM; Reinhold-Keller E
    Dtsch Med Wochenschr; 2005 Aug; 130(33):1871-3. PubMed ID: 16118729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Are anti-TNFAb indicated in systemic necrotizing vasculitides?].
    Guillevin L
    Rev Med Interne; 2005 Oct; 26(10):769-70. PubMed ID: 16039017
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete remission of coronary vasculitis in Churg-Strauss Syndrome by prednisone and cyclophosphamide.
    Riksen NP; Gehlmann H; Brouwer AE; van Deuren M
    Clin Rheumatol; 2013 Mar; 32 Suppl 1(Suppl 1):S41-2. PubMed ID: 20349259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.
    Booth AD; Jayne DR; Kharbanda RK; McEniery CM; Mackenzie IS; Brown J; Wilkinson IB
    Circulation; 2004 Apr; 109(14):1718-23. PubMed ID: 15037536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in the pharmacotherapy of Churg-Strauss syndrome.
    Hellmich B; Gross WL
    Expert Opin Pharmacother; 2004 Jan; 5(1):25-35. PubMed ID: 14680433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.
    Huugen D; Tervaert JW; Heeringa P
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1100-7. PubMed ID: 17699331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological therapies: new treatment options for ANCA-associated vasculitis?
    Aries PM; Lamprecht P; Gross WL
    Expert Opin Biol Ther; 2007 Apr; 7(4):521-33. PubMed ID: 17373903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis.
    Puéchal X; Miceli-Richard C; Mejjad O; Lafforgue P; Marcelli C; Solau-Gervais E; Steinfeld S; Villoutreix C; Trèves R; Mariette X; Guillevin L;
    Ann Rheum Dis; 2008 Jun; 67(6):880-4. PubMed ID: 18037625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Churg-Strauss syndrome--recent developments in diagnosis and treatment].
    Hellmich B; Metzler C; Gross WL
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2270-4. PubMed ID: 17036268
    [No Abstract]   [Full Text] [Related]  

  • 12. Churg Strauss syndrome--successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment.
    Metzler C; Hellmich B; Gause A; Gross WL; de Groot K
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S52-61. PubMed ID: 15675136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-TNF alpha agents in vasculitis].
    Solans Laqué R; Bosch Gil JA
    Med Clin (Barc); 2008 Feb; 130(3):93-4. PubMed ID: 18261379
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon-alpha treatment of four patients with the Churg-Strauss syndrome.
    Tatsis E; Schnabel A; Gross WL
    Ann Intern Med; 1998 Sep; 129(5):370-4. PubMed ID: 9735064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy.
    Taniguchi M; Tsurikisawa N; Higashi N; Saito H; Mita H; Mori A; Sakakibara H; Akiyama K
    Allergol Int; 2007 Jun; 56(2):97-103. PubMed ID: 17460439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept plus standard therapy for Wegener's granulomatosis.
    Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
    N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients.
    Moosig F; Bremer JP; Hellmich B; Holle JU; Holl-Ulrich K; Laudien M; Matthis C; Metzler C; Nölle B; Richardt G; Gross WL
    Ann Rheum Dis; 2013 Jun; 72(6):1011-7. PubMed ID: 22887848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of recurrent uveitis with TNF-alpha inhibitors].
    Falappone PC; Iannone F; Scioscia C; Grattagliano V; Covelli M; Lapadula G
    Reumatismo; 2004; 56(3):185-9. PubMed ID: 15470524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.
    Comarmond C; Plaisier E; Dahan K; Mirault T; Emmerich J; Amoura Z; Cacoub P; Saadoun D
    Autoimmun Rev; 2012 Jul; 11(9):678-84. PubMed ID: 22155781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Churg-Strauss syndrome: diagnosis and treatment].
    Cohen Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2011; 155():A3140. PubMed ID: 21329549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.